Early Catheter Ablation for Unstable Ventricular Tachycardia: Still Too Early to Tell

Affiliations

¹ From the QEII Health Sciences Centre, Halifax, NS, Canada (J.L.S., R.P.); and University of Ottawa Heart Institute, ON, Canada (G.W.). John.sapp@nshealth.ca.
² From the QEII Health Sciences Centre, Halifax, NS, Canada (J.L.S., R.P.); and University of Ottawa Heart Institute, ON, Canada (G.W.).

Editorial

John L Sapp et al. Circ Arrhythm Electrophysiol. 2017 Mar.

. 2017 Mar;10(3):e005110.

doi: 10.1161/CIRCEP.117.005110.

¹ From the QEII Health Sciences Centre, Halifax, NS, Canada (J.L.S., R.P.); and University of Ottawa Heart Institute, ON, Canada (G.W.). John.sapp@nshealth.ca.
² From the QEII Health Sciences Centre, Halifax, NS, Canada (J.L.S., R.P.); and University of Ottawa Heart Institute, ON, Canada (G.W.).

No abstract available

Keywords: Editorials; catheter ablation; coronary artery disease; prognosis; randomized controlled trial; ventricular fibrillation.

Comment on

Impact of Substrate Modification by Catheter Ablation on Implantable Cardioverter-Defibrillator Interventions in Patients With Unstable Ventricular Arrhythmias and Coronary Artery Disease: Results From the Multicenter Randomized Controlled SMS (Substrate Modification Study).
Kuck KH, Tilz RR, Deneke T, Hoffmann BA, Ventura R, Hansen PS, Zarse M, Hohnloser SH, Kautzner J, Willems S; SMS Investigators. Kuck KH, et al. Circ Arrhythm Electrophysiol. 2017 Mar;10(3):e004422. doi: 10.1161/CIRCEP.116.004422. Circ Arrhythm Electrophysiol. 2017. PMID: 28292751 Clinical Trial.